Novo Pharm Formulations Private Limited - Company Profile

It is a pharma private limited company based in Vadodara, Gujarat, India, established in 1995.
1995 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Novo Pharm Formulations Private Limited

Novo Pharm Formulations Private Limited, a active private limited company, was established on 20 March 1995 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231GJ1995PTC025060. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.

It upholds a compliant status. Its leadership includes Ojasbhai Ravjibhai Patel (Director), Jaikrishan Dwarikanath Kotru (Director), Dhwani Ojas Patel (Director). It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 105 Rajmandir Appartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri,, Vadodara, Gujarat, 390007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1995PTC025060

  • Registration Number

    025060

  • Incorporation Date

    20 March 1995

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 31 Year,
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.00 M
  • Revenue Growth **** 34.61%
  • Profit Growth **** 36.68%
  • Ebitda **** 23.69%
  • Net Worth 14.75%
  • Total Assets **** 7.94%
Company report

Novo Pharm Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novo Pharm Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Novo Pharm Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Ojasbhai Ravjibhai Patel Director 25 Oct 1999 Current
Jaikrishan Dwarikanath Kotru Director 27 Mar 2015 Current
Dhwani Ojas Patel Director 13 Dec 2021 Current
Ravjibhai Ashabhai Patel Director 09 Apr 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novo Pharm Formulations.

Novo Pharm Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.61% increase. The company also saw a substantial improvement in profitability, with a 36.68% increase in profit. The company's net worth Soared by an impressive increase of 14.75%.

Novo Pharm Formulations revenue growth over time
Novo Pharm Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 34.61%
*******
*******
*******
*******
Revenue from Operations
*******
 34.75%
*******
*******
*******
*******
Total Assets
*******
 7.94%
*******
*******
*******
*******
Profit or Loss
*******
 36.68%
*******
*******
*******
*******
Net Worth
*******
 14.75%
*******
*******
*******
*******
EBITDA
*******
 23.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novo Pharm Formulations?

In 2022, Novo Pharm Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • The Baroda City Co - Operative Bank Limited : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
29 Dec 2011 The Baroda City Co - Operative Bank Limited ₹0.40 M Open
26 Dec 2011 The Baroda City Co - Operative Bank Limited ₹0.60 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Novo Pharm Formulations?

Unlock and access historical data on people associated with Novo Pharm Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novo Pharm Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Pharm Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novo Pharm Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Novo Pharm Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Novo Pharm Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Dhwani Ojas Patel was appointed as a Director was appointed as a Director on 13 Dec 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Jaikrishan Dwarikanath Kotru was appointed as a Director was appointed as a Director on 27 Mar 2015 & has been associated with this company since 10 years 11 months . was documented.

  • Charges

    The activity A charge with The Baroda City Co - Operative Bank Limited amounted to Rs. 0.40 M with Charge ID 10327943 was registered on 29 Dec 2011. was completed.

  • Charges

    A charge with The Baroda City Co - Operative Bank Limited amounted to Rs. 0.60 M with Charge ID 10327945 was registered on 26 Dec 2011. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novo Pharm Formulations Private Limited?

The CIN of Novo Pharm Formulations Private Limited is U24231GJ1995PTC025060.

Where is Novo Pharm Formulations Private Limited headquartered?

Novo Pharm Formulations Private Limited is headquartered at 105 Rajmandir Appartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri,, Vadodara, Gujarat, 390007.

When was Novo Pharm Formulations Private Limited incorporated?

Novo Pharm Formulations Private Limited was incorporated on 20 March 1995.

Who are the current directors of Novo Pharm Formulations Private Limited?

The current directors of Novo Pharm Formulations Private Limited are

What is the primary industry of Novo Pharm Formulations Private Limited?

The primary industry of Novo Pharm Formulations Private Limited is Trade.

Is Novo Pharm Formulations Private Limited a listed company?

Novo Pharm Formulations Private Limited is unlisted.

What is the capital structure of Novo Pharm Formulations Private Limited?

The authorized capital of Novo Pharm Formulations Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.

What is the compliance status of Novo Pharm Formulations Private Limited?

The compliance status of Novo Pharm Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available